The Foundation has been invited to attend the Medical College of Wisconsin’s “Updates in Gastrointestinal Oncology” on March 23rd. The program will cover foregut, liver, pancreas, colorectal, and regional approaches to advanced malignancies. The guest faculty will be Dr. Timothy M. Pawlik, Associate Professor of Surgery and Chief of Surgical Oncology from Johns Hopkins. The lectures will review recent abstracts from the ASCO® GI Symposium Meeting in San Francisco earlier this year, and focus on the multidisciplinary advances being made in the field. Ample discussion time has been built into the program as well as case presentations highlighting interventional, radiation and transplant approaches in gastrointestinal cancer.
Exciting things are happening in Washington D.C. in April. CanLiv -The Hepatobiliary Cancer Foundation is holding its 3rd Symposium on April 5th, 2013 and immediately before the beginning of AACR- American Association for Cancer Research Annual Meeting held April 6-10. Further information is included at the link below:
The 3rd Annual “Andrea’s Night” took place on January 12, 2013 and was a huge success. 500 people were in attendance including Harlem Globe trotter Meadow Lark Lemon and retired St Louis Cardinal pitcher Al Hrabarski who both generously donated items to the auction. A total of 31 live auction items, 108 silent auction items and 4 Aching Acres Landscape 10K design and build packages helped to raise $78,000. The Cholangiocarcinoma will be recieving a generous donation of $20,000 while the remaining funds will continue to grow Andrea’s Scholarship fund to the University of Southern Indiana. The Scholarship fund total will be up to $160,545.90 which is one year shy of hitting its goal amount of $200,000. Amazing Work Andrea’s Night and Thank you from the Foundation and all the good work it can continue to provide.
Webinar on Hepatobiliary Neoplasia Registry and Biorepository
Join us on Monday, February 11 at 12:00 p.m. eastern (9:00 a.m. pacific) for a presentation by Dr. Lewis R. Roberts from the Mayo Clinic in Rochester, MN on the three main types of studies he is performing regarding cholangiocarcinoma (bile duct cancer). Included will be details on the:
Research Plan: The collected samples will be used for three main types of studies:
1. DNA samples from patients with cholangiocarcinoma will be used for a genome-wide association study to determine the genetic variants that confer risk for cholangiocarcinoma.
2. Serum samples from patients with cholangiocarcinoma will be used to validate new biomarkers for early detection and diagnosis of cholangiocarcinoma.
3. Tissue samples obtained at surgical resection will be implanted into immunodeficient mice to create patient derived xenografts and will also be snap frozen in liquid nitrogen for future comprehensive genome-wide molecular analyses such as is performed by the National Cancer Institutes Cancer Genome Atlas Project (TCGA).
This is one of four research grants funded in 2012 by the Cholangiocarcinoma Foundation. Thank you to everyone who supports us. We could not do it without you.
More research grant webinars are scheduled for later this month. Check back for more details soon.